[18] Semaglutide (Wegovy) is now available through NHS specialist weight management services for adults with at least one weight-related comorbidity and a BMI of 35 kg/m or above (or 32.5 kg/m for certain ethnic groups), as recommended in NICE TA875
The anti-inflammatory properties of both peptides may contribute to joint health maintenance through reduction of inflammatory mediators that contribute to cartilage breakdown
Sobo to discuss recovery concerns, peptide therapy questions, PRP, injury history, and whether a physician-guided plan may be appropriate
The longer someone uses tirzepatide, the greater their risk of developing B12 insufficiency or outright deficiency
Dont stop taking a GLP-1 without talking to your doctor first
Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C: Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses
